Viewing Study NCT02391194


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2026-03-01 @ 8:59 PM
Study NCT ID: NCT02391194
Status: COMPLETED
Last Update Posted: 2017-03-22
First Post: 2015-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery
Sponsor: Avelas Biosciences, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AVB-620 View
None stage I View
None newly diagnosed View
None breast cancer View
None stage II View
None stage III View
None ductal carcinoma in situ View